12:00 AM
Mar 12, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tofacitinib regulatory update

FDA's Arthritis Advisory Committee will meet on May 9 to discuss an NDA from Pfizer for tofacitinib to treat adults...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >